UPC Analytics
DEEN
Übersicht · Eingereicht: —

APL_39664/2024

ANALYTE SENSOR DEVICES, CONNECTIONS, AND METHODS

BerufungenHauptberufungCourt of AppealAppeal RoP220.1—
ÜbersichtEntscheidungenZitateDokumenteZeitverlauf
Parteien

Kläger

Vertreter: Wim Maas (Taylor Wessing); Eelco Bergsma (Taylor Wessing); Geert Theuws (Taylor Wessing); David Mulder (Taylor Wessing); Iris van der Heijdt (Taylor Wessing); Peter Haartsen (AOMB); Raimon Haan (AOMB); Teun van Berkel (AOMB)

Beklagte

  • Sibio Technology Limited
  • Umedwings Netherlands B.V.
Vertreter: Thomas Gniadek (Simmons & Simmons LLP); Sebastian Horleman (Simmons & Simmons LLP); Fritz Lahrtz (Simmons & Simmons LLP); Diptanil Debbarma (Simmons & Simmons LLP)
Richter
  • Rian KaldenPresiding judge and judge-rapporteur
  • Ingeborg SimonssonLegally qualified judge
  • Patricia RombachLegally qualified judge
  • Patrik RydmanTechnically qualified judge
  • Marc van der BurgTechnically qualified judge
Patente
  • EP 3 831 283
CPC-Codes: A61B5/1451, H04L67/12, A61B5/15087, A61B5/145, A61B5/150022, A61B5/150335, A61B5/14503, A61B5/6849, A61B5/0004, A61B5/14532, A61B5/150503, A61B5/150877…

Sektor: Pharmaceutical & Medical

Ausgang
PI erteilt
Eingereicht: —
Erste Entscheidung: 14. Feb. 2025
Sprache: —

Court of Appeal Panel 2 set aside the The Hague Local Division's refusal to grant provisional measures, and granted a preliminary injunction in favour of Abbott Diabetes Care Inc. against Sibio Technology Limited and Umedwings Netherlands B.V. concerning EP 3 831 283 (continuous glucose monitoring device). The Court found the patent valid (overcoming added matter and other validity challenges) and likely infringed by Sibionics' GS1 Device. A general injunction was ordered against all infringing acts in UPC Contracting Member States. Sibionics was also ordered to provide origin/distribution chain information and to deliver up infringing products. Penalty payments of EUR 10,000 per infringing product or EUR 100,000 per day were imposed.